Private care Magazine
Mr Declan Cahill specialises in the diagnosis and management of patients with prostate cancer at The Royal Marsd
The pain management team has launched a new implantable drug infusion system to help patients control the pain that is commonly associated with cancer and improve their quality of life.
Using the body’s immune cells to target cancer, cellular therapies are showing great promise – and The Royal Marsden is at the forefront.
Combining Immunotherapy with an experimental cancer drug could offer a new way of treating some patients with aggressive brain cancers, according to early results from the Phase 1 Ice-CAP trial, le
Our prehabilitation service works with patients to ensure they are physically and mentally ready to undergo cancer treatment such as surgery.
In June, experts from The Royal Marsden presented the results of their pioneering research to a global online audience at the American Society of Clinical Oncology (ASCO) Annual Meeting, the world’s largest cancer conference.